E.Michael Egan
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
Papers in
-
- Acute Myeloid Leukemia Research 3
-
- DNA and Nucleic Acid Chemistry 10
- DNA Repair Mechanisms 6
- Cancer therapeutics and mechanisms 2
- Biochemical and Molecular Research 2
- Co-authors
- Donald KüfePierre MajorG. Peter BeardsleyDonald G. MunroeDavid R. SpriggsD HerrickMarcus Dühren-von MindenDavid J. Herrick
- Journals
- Biochemical Pharmacology (5 papers)Journal of Biological Chemistry (2 papers)Molecular Pharmacology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Blood (2 papers)
- Partner nations
- United States
In The Last Decade
E.Michael Egan
18 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Hematology 281
- Oncology 330
- Molecular Biology 815
- Genetics 111
- Public Health, Environmental and Occupational Health 279
Countries citing papers authored by E.Michael Egan
This map shows the geographic impact of E.Michael Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.Michael Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.Michael Egan more than expected).
Fields of papers citing papers by E.Michael Egan
This network shows the impact of papers produced by E.Michael Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.Michael Egan. The network helps show where E.Michael Egan may publish in the future.
Co-authorship network
The 17 scholars most cited alongside E.Michael Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 7 | |
| 2 | 1984 | 133 | |
| 3 | 1984 | 86 | |
| 4 | 1984 | 35 | |
| 5 | 1983 | 13 | |
| 6 | 1983 | 1 | |
| 7 | 1983 | 11 | |
| 8 | 1982 | 9 | |
| 9 | 1982 | 17 | |
| 10 | 1982 | 116 | |
| 11 | 5-Fluorouracil incorporation in DNA of human breast carcinoma cells. | 1982 | 99 |
| 12 | 1981 | 166 | |
| 13 | 1981 | 89 | |
| 14 | 1981 | 9 | |
| 15 | 1981 | 43 | |
| 16 | 1980 | 307 | |
| 17 | 1979 | 2 | |
| 18 | Hepatic arterial BCNU: a pilot clinical-pharmacologic study in patients with liver tumors. | 1978 | 8 |
About E.Michael Egan
E.Michael Egan is a scholar working on Hematology, Molecular Biology, Genetics, Pharmaceutical Science and Clinical Biochemistry, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (10 papers), DNA Repair Mechanisms (6 papers), Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer therapeutics and mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Biochemical and Molecular Research (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Hematology (281 citations), Oncology (330 citations), Molecular Biology (815 citations), Genetics (111 citations) and Public Health, Environmental and Occupational Health (279 citations). E.Michael Egan has collaborated with scholars based in United States. Frequent co-authors include Donald Küfe, Pierre Major, G. Peter Beardsley, Donald G. Munroe, David R. Spriggs, D Herrick, Marcus Dühren-von Minden, David J. Herrick, D Kufe and Robert J. Fram. Their work appears in journals such as Biochemical Pharmacology, Journal of Biological Chemistry, Molecular Pharmacology, Cancer Chemotherapy and Pharmacology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.